Brief: Relief Therapeutics Says Partner NRX Pharmaceuticals Submitted Application For Emergency Use Authorization For Aviptadil To FDA

MindMaze Therapeutics Holding SA

02/06/2021 06:05

June 2 (Reuters) - RELIEF THERAPEUTICS Holding SA  RLFB.S :
    * REPORTS THAT ITS COLLABORATION PARTNER, NRX
PHARMACEUTICALS, HAS
SUBMITTED AN APPLICATION FOR EMERGENCY USE AUTHORIZATION FOR
AVIPTADIL TO U.S. FOOD & DRUG ADMINISTRATION

Source text for Eikon:  ID:nEQc87DpMa 
Further company coverage:  RLFB.S 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))